Ukrainian Pharma: challenges and opportunities Pharmaceutical Industry Review, special issue, December 2022
Eugene Zaika, General Director, ACINO Ukraine, Chairman of the Supervisory Board, PHARMA START, CIS Regional Head, ACINO
and promote new medicines for patients.
Medicinal drugs logistics During the first months of the war despite complicated logistics ACINO supplied medicines immediately from the transportation means to distributors’ warehouses. As of today, this amount exceeded 17,5 M packages of medicines. In addition, the company organized deliveries of the most needed drugs from its warehouses in Switzerland.
Partnership To ensure continuous medicines supply to patients, ACINO organized regular delivery of raw materials for drug manufacturing to its plant in Kyiv, we also constantly keep in touch with our international partners – medicines producers.
Humanitarian aid and material assistance Being a highly socially responsible company ACINO, since the beginning of its operations in Ukraine (01.10.2015), always provides humanitarian aid to local medical institutions in form of medicines supply from its product
60 BACK TO CONTENTS
portfolio, as well as supports several charity projects and promotes its social initiatives. Every year, there are tens of millions of hryvnias aimed at supporting patients, developing medical education, rebuilding hospitals, etc. Since the beginning of the war ACINO in Ukraine provided UAH 65 M for humanitarian purposes and supplied over 200 K packages of medicines used in neurology, psychiatry, cardiology, general therapy and endocrinology for the total amount of UAH 57 M. Thousands of Ukrainian citizens received this aid through over 225 clinics, military hospitals, non-government organizations and charity foundations. We provided UAH 2 M for support of the Ukrainian Armed Forces, and transferred UAH 4 M for the humanitarian and medical needs of the Ministry of Health of Ukraine within the global initiative of the President of Ukraine UNITED24. ACINO supported charity foundation Nestrymni with UAH 2 M aid for the purchase of 4 cars for humanitarian assistance transportation, relocation and evacuation of the civil
«Pharmaceutical sector is one of the most important components of the Ukrainian healthcare industry. Consistent activities, development and competitiveness of pharma market players, especially during the war, facilitate access to necessary medicines for Ukrainians, as well as guarantee the industry’s development in general. Starting the first day of the russian military invasion our pharmaceutical plant team members secured the functioning of the critical infrastructure systems in 24/7 mode taking risks of their own lives to avoid medicines shortages in the market. On March 8 our manufacturing plant started the release of the batches produced at the beginning of the war, while on March 29 the full cycle of manufacturing operations was resumed. We also distributed our products according to our partner contract manufacturing commitments to meet the patients’ demands in Ukraine and friendly neighboring countries such as Georgia and Moldova. In total today ACINO manufacturing plant in Ukraine supplies medicines to 7 countries – Azerbaijan, Armenia, Georgia, Kazakhstan, Moldova, Uzbekistan and Kuwait. Despite the war, we strengthened our export potential with the first registration in EU of the medicine produced by our plant. I am confident that such an extension of export geography by ACINO, the TOP-3 player in the Ukrainian pharma market, will support the economy of the country. ACINO plans no deviations from its development strategy. We have many plans for the post-war time. We continue investments in the modernization of our plant in Kyiv. During the last 7 years investments in the manufacturing plant totaled USD 30 M. This year we accelerated the development of our medicines using our R&D center. We establish new strategic partnerships with international pharmaceutical companies including members of Big Pharma».
www.promoboz.com
www.promoboz.com |
www.cphem.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
